Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigerase vs Pulmozyme in Cystic Fibrosis
NCT04468100Phase 3Completed
- Sponsor
- Generium
- Start
- Aug 2017
- Primary completion
- May 2018
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dornase alfa in cystic fibrosis (CF), sponsored by Generium. Started Aug 2017; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04468100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468100.